XML 216 R187.htm IDEA: XBRL DOCUMENT v3.22.4
IFRS 7 Disclosures - Additional Information (Detail)
$ in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
CAD ($)
Dec. 31, 2021
CAD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
CAD ($)
Dec. 31, 2020
USD ($)
Financial Instruments - Disclosures under IFRS 7 [line items]            
Total unencumbered assets $ 477,700 $ 502,400        
Dynamically hedged variable annuity guarantee best estimate liabilities, rebalancing percentage intervals 5.00%          
Variable annuity guarantee liabilities, rebalanced basis point intervals 20.00%          
50 basis point decrease in interest [member]            
Financial Instruments - Disclosures under IFRS 7 [line items]            
Sensitivity of net income attributed to shareholders 50.00%          
Sensitivity of our net income attributed to shareholders due to change in interest rate $ 100          
50 basis point increase in interest [member]            
Financial Instruments - Disclosures under IFRS 7 [line items]            
Sensitivity of net income attributed to shareholders 50.00%          
Sensitivity of our net income attributed to shareholders due to change in interest rate $ 100          
Unsecured revolving credit facility [Member] | Canadian chartered banks [Member]            
Financial Instruments - Disclosures under IFRS 7 [line items]            
Estimated maximum borrowing capacity         $ 500  
Unsecured revolving credit facility [Member] | U.S.banks [Member]            
Financial Instruments - Disclosures under IFRS 7 [line items]            
Estimated maximum borrowing capacity           $ 500
Amounts outstanding     $ 0 $ 0    
FHLBI facility [Member]            
Financial Instruments - Disclosures under IFRS 7 [line items]            
Estimated maximum borrowing capacity     3,800 4,400    
Amounts outstanding     $ 500 $ 500    
10% [member]            
Financial Instruments - Disclosures under IFRS 7 [line items]            
Percentage of expected changes in market values of publicly traded equities 10.00% 10.00%        
20% [member]            
Financial Instruments - Disclosures under IFRS 7 [line items]            
Percentage of expected changes in market values of publicly traded equities 20.00% 20.00%        
30% [member]            
Financial Instruments - Disclosures under IFRS 7 [line items]            
Percentage of expected changes in market values of publicly traded equities 30.00% 30.00%